Growth hormone therapy in Prader–Willi Syndrome
Open Access
- 25 January 2001
- journal article
- review article
- Published by Springer Nature in International Journal of Obesity
- Vol. 25 (1) , 2-7
- https://doi.org/10.1038/sj.ijo.0801518
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Effect of growth hormone on height, weight, and body composition in Prader-Willi syndromeArchives of Disease in Childhood, 1998
- Growth hormone treatment of children with Prader‐Willi syndrome affects linear growth and body composition favourablyActa Paediatrica, 1998
- Ethical issues in emerging new treatments such as growth hormone therapy for children with Down syndrome and Prader-Willi syndromeCurrent Opinion in Pediatrics, 1996
- Body Composition and Tissue Distributions in Growth Hormone Deficient Adults Before and After Growth Hormone TreatmentObesity Research, 1996
- High resolution chromosome analysis and fluorescence in situ hybridization in patients referred for Prader‐Willi or Angelman syndromeAmerican Journal of Medical Genetics, 1995
- Effects of Growth Hormone in Prader-Willi SyndromeClinical Pediatrics, 1993
- Growth Hormone (GH) Response to Combined Pyridostigmine and GH-Releasing Hormone Administration in Patients with Prader-Labhard-Willi SyndromeHormone Research, 1993
- Changes in body composition and energy expenditure after six weeks' growth hormone treatment.Archives of Disease in Childhood, 1991
- Impaired Growth Hormone Responses to Growth Hormone–Releasing Factor in ObesityNew England Journal of Medicine, 1984
- Immunoreactive insulin and growth hormone responses in patients with Prader-Willi syndromeThe Journal of Pediatrics, 1973